201 Lyons Ave, Newark, NJ, 07112 · (973) 926-7000
Beds
419
FY 2025
Star rating
2 of 5
Patient survey: 2 of 5
Net patient revenue
$874.6M
FY 2025
Net income
$38.2M
Patient care margin -5.0%
Discharges
19,530
Occupancy 80.1%
Clinicians
501
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $874.6M | $918.7M | -5.0% | $38.2M | 19,530 | $63.6M | 10.6% | 11.7% |
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
| Death rate after heart bypass surgery | 2.6% | US median 2.3% |
| Death rate for COPD patients | 8% | US median 8.5% |
| Death rate for heart attack patients | 12.7% | US median 11.8% |
| Death rate for heart failure patients | 11% | US median 11% |
| Hospital-wide death rate within 30 days | 3.1% | US median 3.9% |
| Death rate for pneumonia patients | 14.5% | US median 15.2% |
| Death rate for stroke patients |
Medicare clinicians who list this hospital, by specialty
Inpatient stays by diagnosis related group (DRG), 2024
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
Medicare clinicians who work here
| 2024 | $807.9M | $880.3M | -8.9% | $690K | 19,613 | $70.3M | 12.2% | 15.1% |
| 2023 | $747.5M | $811.0M | -8.5% | $3.8M | 18,338 | $49.5M | 12.6% | 13.6% |
| 2022 | $669.9M | $731.0M | -9.1% | -$6.4M | 17,861 | $50.1M | 13.8% | 11.4% |
| 2021 | $605.3M | $689.1M | -13.8% | $3.7M | 17,466 | $42.8M | 16.1% | 10.0% |
| 2020 | $522.7M | $632.1M | -20.9% | $11.2M | 14,509 | $42.5M | 16.8% | 13.9% |
| 10.2% |
| US median 11.6% |
| Readmission rate after heart bypass surgery | 10.6% | US median 10.9% |
| Readmission rate for COPD | 20% | US median 19.8% |
| Readmission rate after a heart attack | 14.8% | US median 14.4% |
| Readmission rate for heart failure | 22% | US median 21.3% |
| Readmission rate for pneumonia | 17.1% | US median 17.2% |
| Serious complications (patient safety composite) | 0.96 | US median 0.96 |
| C. diff intestinal infections (ratio to expected) | 0.09 | US median 0.28 · better |
| Central line bloodstream infections (ratio to expected) | 0.28 | US median 0.48 · better |
| Surgical site infections after colon surgery (ratio to expected) | 0.88 | US median 0.72 |
| Surgical site infections after hysterectomy (ratio to expected) | 2.21 | US median 0.81 |
| MRSA bloodstream infections (ratio to expected) | 0.79 | US median 0.60 |
| Catheter urinary tract infections (ratio to expected) | 0.36 | US median 0.40 · better |
| Doctors always communicated well | 76% | US median 79% |
| Nurses always communicated well | 73% | US median 80% |
| Patient survey summary star rating | 2 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 53% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 63% | US median 72% |
| Room and bathroom always clean | 66% | US median 73% |
| Patients who would definitely recommend the hospital | 64% | US median 71% |
| Patients who left the emergency department before being seen | 2% | US median 1% |
| Median time in the emergency department before leaving (minutes) | 176 min | US median 148 min |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 15% | US median 15% |
| Patients who got appropriate care for severe sepsis and septic shock | 85% | US median 65% |
| Healthcare workers given the flu vaccine | 96% | US median 79% |
| 63 |
| $79,581.60 |
| $11,530.98 |
| $7,177.67 |
| DRG 274 PERCUTANEOUS AND OTHER INTRACARDIAC PROCEDURES WITHOUT MCC | 39 | $78,525.15 | $31,882.51 | $24,748.54 |
| DRG 853 INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH MCC | 39 | $490,379.31 | $64,783.00 | $40,556.82 |
| DRG 280 ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MCC | 37 | $140,604.00 | $16,857.62 | $12,400.10 |
| DRG 870 SEPTICEMIA OR SEVERE SEPSIS WITH MV >96 HOURS | 36 | $612,337.17 | $75,235.31 | $58,777.93 |
| DRG 267 ENDOVASCULAR CARDIAC VALVE REPLACEMENT AND SUPPLEMENT PROCEDURES WITHOUT MCC | 29 | $156,434.28 | $48,615.72 | $40,566.75 |
| DRG 872 SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC | 28 | $107,817.54 | $11,397.64 | $7,681.44 |
| DRG 640 MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITH MCC | 27 | $148,297.59 | $16,274.33 | $10,642.23 |
| DRG 682 RENAL FAILURE WITH MCC | 21 | $131,910.24 | $14,952.90 | $11,457.18 |
| DRG 811 RED BLOOD CELL DISORDERS WITH MCC | 21 | $153,909.86 | $17,690.14 | $11,545.76 |
| DRG 252 OTHER VASCULAR PROCEDURES WITH MCC | 21 | $325,448.29 | $39,014.10 | $29,696.95 |
| DRG 884 ORGANIC DISTURBANCES AND INTELLECTUAL DISABILITY | 18 | $137,229.89 | $18,873.33 | $13,593.39 |
| DRG 193 SIMPLE PNEUMONIA AND PLEURISY WITH MCC | 17 | $136,845.35 | $15,673.41 | $9,867.73 |
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 8011 Comprehensive Observation Services | 231 | 197 | $2,288.74 | $2,090.36 |
| APC 5191 Level 1 Endovascular Procedures | 128 | 126 | $2,449.26 | $2,207.96 |
| APC 5193 Level 3 Endovascular Procedures | 58 | 56 | $9,467.93 | $8,873.86 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | 55 | 44 | $1,380.67 | $1,219.56 |
| APC 5362 Level 2 Laparoscopy and Related Services | 49 | 49 | $9,218.38 | $8,164.45 |
| APC 5183 Level 3 Vascular Procedures | 47 | 32 | $2,665.83 | $2,405.01 |
| APC 5374 Level 4 Urology and Related Services | 30 | 27 | $2,782.05 | $2,629.24 |
| APC 5232 Level 2 ICD and Similar Procedures | 27 | 27 | $31,106.34 | $29,374.70 |
| APC 5192 Level 2 Endovascular Procedures | 25 | 24 | $4,868.94 | $4,338.16 |
| APC 5375 Level 5 Urology and Related Services | 24 | 23 | $4,420.42 | $3,917.51 |
| APC 5213 Level 3 Electrophysiologic Procedures | 23 | 22 | $23,807.93 | $21,117.37 |
| APC 5194 Level 4 Endovascular Procedures | 22 | 22 | $17,148.42 | $14,606.35 |
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 4 | $255K |
| Edwards Lifesciences Corporation EW | 19 | $56K |
| Abbott Laboratories ABT | 14 | $37K |
| Janssen Research & Development, LLC JNJ | 13 | $33K |
| Boston Scientific Corporation BSX | 18 | $22K |
| ZOLL Circulation Inc | 1 | $14K |
| Cleerly, Inc. | 3 | $9,440 |
| Global Blood Therapeutics, Inc. PFE | 1 | $3,000 |
| Pfizer Inc. PFE | 1 | $2,500 |
| Haemonetics Corporation HAE | 2 | $1,878 |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Newark Beth Israel Medical Center is a nonprofit short-term acute care hospital in Newark, NJ with 419 beds, part of RWJBarnabas Health and a 2-star overall rating.
Newark Beth Israel Medical Center in Newark, NJ has 419 beds (fiscal year 2025 cost report); 665 beds are certified for Medicare. It discharged 19,530 inpatients that year, with 80.1% of its beds in use on average.
In fiscal year 2025 (ending 2025-12-31), Newark Beth Israel Medical Center reported net patient revenue of $874.6M and operating expenses of $918.7M, a margin on patient care of -5.0%. After other income and expenses its net income was $38.2M (4.0% of revenue), so it made a profit that year.
Newark Beth Israel Medical Center is part of RWJBarnabas Health, a health system with 15 hospitals based in West Orange, NJ. It is a nonprofit hospital.
Newark Beth Israel Medical Center has an overall rating of 2 out of 5 stars in the official hospital quality ratings. Patients rate it 2 out of 5 stars in the patient survey.
Yes, Newark Beth Israel Medical Center provides emergency services.
501 Medicare clinicians list Newark Beth Israel Medical Center as a hospital they work at, most often in Internal Medicine, Nurse Practitioner, Certified Registered Nurse Anesthetist (Crna).
In 2024, Newark Beth Israel Medical Center had 860 Medicare inpatient stays in 35 diagnosis groups. The most common was DRG 871 (septicemia or severe sepsis without mv >96 hours with mcc) with 137 stays; Medicare paid $20,928.57 per stay on average, compared with $15,524.21 across all hospitals.
In 2025, companies reported $439K in payments to Newark Beth Israel Medical Center as a teaching hospital ($263K general and $176K for research) from 16 companies.